News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
PharmaBlock Sciences has named Dr. Shijie Zhang as chief technology officer.
Shijie joins the company from Agios Pharmaceuticals, Inc., where he was director of process chemistry and API manufacturing, CMC.
“I am delighted to join PharmaBlock, and I have witnessed its remarkable and rapid growth. With its strong leadership role in building blocks business, and impressive progress in process chemistry capabilities, PharmaBlock has solid foundation to win in CDMO business,” said Zhang.
“I look forward to working with the tremendous team, and helping the team better understand the sponsor’s challenges, deliver development work, or commercial manufacture in line with the sponsor’s expectations, and contribute scientific, manufacturing, and operational expertise that keeps their project on track.”
The China-headquartered CDMO also recently purchased a GMP compliant manufacturing facility and is investing in new technology and capacity.